Alyeska Investment Group’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.53M	Hold	125,000	–	–	0.01%	485
2025 Q1	$1.38M	Buy	+125,000	New	+$1.38M	0.01%	425